Amelenodor

N/A

Report date: 2025/12/22 10:29:45
NME

Base Information

Drug NameAmelenodor
Drug Alias NameNX-13ABBV-113
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNLR family member X1 agonists
TargetsNLR family member X1
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesUkraine +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLandos Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospitals LeuvenKu LeuvenLandos Biopharma Inc +[4] 
Inactive CompaniesAbbvie Inc
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A